相关实验视频
Updated: Jun 29, 2025
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
布和阿尔茨海默氏症的疾病
Abigail L Kehrer-Dunlap1, Audrey A Keleman1, Rebecca M Bollinger1
1Program in Occupational Therapy, Washington University in St. Louis School of Medicine, 4444 Forest Park Ave., Box 8505, St. Louis, MO 63110, USA.
Advances in geriatric medicine and research
|March 29, 2024
概括
老年人,尤其是阿尔茨海默氏病 (AD) 患者,跌倒是他们的主要风险. 需要更多的研究来开发有效的防摔策略,以治疗症状和临床前阿尔茨海默病.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 跌倒是老年人受伤和死亡的主要原因.
- 患有阿尔茨海默氏症 (AD) 的老年人体验下降率是认知正常个体的两倍多.
- 对于认知障碍的人来说,现有的防摔策略对认知障碍的人来说效果较差.
研究的目的:
- 审查症状性阿尔茨海默病 (AD) 的跌倒风险因素.
- 为了检查证据,在有症状的阿尔茨海默病中进行预防跌倒的干预措施.
- 探索临床前AD作为未来跌倒研究和预防的目标.
主要方法:
- 这篇小小的综述综合了有关阿尔茨海默病 (AD) 跌倒的现有文献.
- 它分析了症状和临床前AD的内在和外在跌倒风险因素.
- 该审查评估了当前防摔干预措施的有效性.
主要成果:
- 患有阿兹海默症的老年人面临着由于认知变化,运动障碍,多药和环境危害而造成的重大跌倒风险.
- 目前针对阿尔茨海默氏症的防摔干预措施有限且没有确定性.
- 在阿尔茨海默病的临床前阶段可能会发生倒,这表明需要早期检测.
结论:
- 对于早期检测和量身定制的干预措施至关重要,以减少阿尔茨海默氏症患者的跌倒风险.
- 了解临床前AD的跌倒风险因素对于开发有效,精确的跌倒预防策略至关重要.
- 建议进行进一步的研究,以提高对风险人群中跌倒的理解和预防.
更多相关视频
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
7.9K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
相关概念视频
01:26Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
01:22Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
01:23Role of Neurotransmitters in Memory
547
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
547
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
01:13Amnesia
123
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
123